# P3 Health Partners Inc. (PIII) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Health Care Providers. Price $3.84, market value $783 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). P3 Health Partners Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 0.5×**. Each dollar of revenue is priced at 0.5×, a low multiple typical of thin-margin businesses or out-of-favour stocks.

## Profitability
- **Operating margin: -9.9%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -10.1%**. The company reported a net loss over the last twelve months.
- **Return on equity: 95.3%**. A 95.3% return on equity is extremely high; check whether buybacks or debt have shrunk the equity base, which flatters the ratio.
- **Return on invested capital: -126.0%**. Return on all capital, debt included, is -126.0%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -15.0%**. Each dollar of assets produces -15.0% of profit.

## Growth
- **Revenue growth (1 yr): -2.8%** (3-yr 11.6%/yr, 5-yr 58.6%/yr). Revenue fell 2.8% over the last year, against 58.6% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 16.3%**. Earnings per share rose 16.3%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Net debt / EBITDA: net cash**. P3 Health Partners Inc. holds more cash than debt.
- **Current ratio: 0.24** (quick 0.24). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: 0.37**. A Z-score of 0.37 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 2/9**. 2 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. P3 Health Partners Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -54.3%** (YTD 14.6%, 3-mo -60.1%). The shares are down 54.3% over twelve months including dividends.
- **From 52-week high: -77.3%** (152.6% above the low). Trading 77% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 32**. An RSI of 32 is neutral.
- **Beta (1 yr): -1.38** (volatility 219%). Beta of -1.38 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=PIII · Page: https://foliofundamentals.com/stocks/piii

Not investment advice.